OSMI-1
SIGMA/SML1621 - ≥98% (HPLC)
Synonym: (αR)-α-[[(1,2-Dihydro-2-oxo-6-quinolinyl)sulfonyl]amino]-N-(2-furanylmethyl)-2-methoxy-N-(2-thienylmethyl)-benzeneacetamide; OSMI 1
CAS Number: 1681056-61-0
Empirical Formula (Hill Notation): C28H25N3O6S2
Molecular Weight: 563.64
Linear Formula: C28H25N3O6S2
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C28H25N3O6S2/c1-36-25- |
InChI key | IYIGLWQQAMROOF-HHHXNRCGSA |
Quality Level | 100 |
SMILES string | O=C(N1)C=CC2=C1C=CC(S(N[C |
solubility | DMSO: 20 mg/mL, clear |
storage temp. | 2-8°C |
Application: | OSMI-1 (OGT with a small molecule inhibitor) has been used in proximal ligation assay, Sox2 (SRY (sex determining region Y)-Box 2 ) dual luciferase reporter assay, Sox2 ELISA (enzyme linked immunosorbent assay) and other in vivo approaches, to study the O-Linked β-N-acetylglucosamine (O-GlcNAc) mediated regulation of self-renewal genes in cancer. It has also been used to study the Hippo pathway regulation mediated by O-GlcNAc transferase. |
Biochem/physiol Actions: | OGT catalyses the attachment of N-acetylglucosamine moieties to a number proteins during post-translational modification. Inhibition of OGT activity might hinder the rate of viral replication in infections such as Herpes simplex viral disease. |
Biochem/physiol Actions: | OSMI-1 is a cell permeable inhibitor of OGT (O-GlcNAc transferase). |
Packaging: | 5, 25 mg in glass bottle |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |